About one quarter of patients with overactive bladder were taking their initial oral regimen at nearly 3 years, yet most ...

Claims data show evidence of HIV virus in 5 of 2913 long-acting cabotegravir users and higher adherence vs oral therapy.

Real-world data show antifibrotic dose reductions in IPF were not significantly linked to faster disease progression vs ...

Naim Alkhouri, MD, on real-world resmetirom results, when biopsy is still needed, choosing a GLP-1 or resmetirom, and access ...

Sputum is considered a noninvasive marker of airway inflammation, and its color is an indicator of bronchiectasis disease ...

James D. Chambers, PhD, MPharm, MSc, discusses US biosimilar adoption and opportunities to expand patient access and lower ...

A poster at the ASCO Quality Care Symposium describes how a value-based care partnership used prior authorization data and ...

Experts at AMCP Nexus say biosimilar launches should prompt payers to revisit step therapy and measure value beyond market share.

Telehealth surpasses out-of-state travel for abortion care in total-ban states in 2025, and a second study suggests telehealth and clinic patients differ.

Data presented at ESMO Congress 2026 show lifileucel met its feasibility end point in refractory sarcoma, with 80% disease ...

UAB experts said new bladder cancer, myeloma, and lung cancer therapies are changing care, but access and costs remain barriers.

Single-discipline autism guidelines that fail Institute of Medicine standards risk omitting critical developmental domains, potentially distorting care coverage and clinical decisions for children ...